Dear Etorians, GE HealthCare forecasts full-year growth for 2024 following fourth-quarter results. GE HealthCare Technologies reported better-than-expected fourth-quarter results, driven by gains in nearly all of its segments, while the global medical technology company expects 2024 earnings to be higher than a year earlier. The company is currently valued at 24 times net. I decided to allocate a significant part of my portfolio there. $GEHC $NSDQ100 $SPX500